BMW Motorrad has started the pre-launch bookings for the new BMW G 310 RR in the Indian market. The company is preparing space for the launch of new mid-level sports bikes and hence is entering this segment as well. Till now BMW has been selling premium bikes in the Indian market. The new 310 cc bike is expect to get more consumers once it is launch on 15th July. This is expected to further expand the company’s base in the Indian market.
Look and Design.
The company has released the teaser of this new bike. Based on this, the design of the BMW G 310 RR closely matches the design elements of the Apache RR 310. It can also called a rebadged version of the RR 310. The company has also given a glimpse of the upcoming bike’s color scheme and new sticker design. This bike has given red, blue and purple livery which gives it a special look.
Engine power.
The mechanics of the bike along with the looks should be exactly the same as the Apache. It will get the same 310 cc single-cylinder engine. This engine is also used in the BMW G 310 Twins, This engine generates maximum power of 34 hp and peak torque of 27.3 Nm. This engine is mated to a 6-speed manual gearbox.
Also Read – Corona’s speed increased in Delhi, 795 new cases in 24 hours
Platform.
The platform used in the new BMW G 310 RR has developed in partnership with the company’s TVS Motors. Both the companies will use the platform for their models. It is worth noting that the same platform will be available in the BMW G 310 GS adventure-tourer. Apart from this, it is the same platform that has used in the TVS Apache RR 310. Apart from this, the new mid-level sports bike will be similar to the RR 310.
How much will the price be?
The price of the new BMW RR 310 is expected to be around the Apache RR 310. However, there is speculation that the bike will cost around Rs 2.90 lakh (ex-showroom). After launching, this bike will compete with bikes like KTM RC 390 in its segment in the Indian market.
Also Read – Coronavirus : 8,329 new cases of corona were registered in India in the last 24 hours, 10 patients died.
